![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_8716d1379fc9fcdaef8beabc3dd79da1.svg) | N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide | IC50 | 24000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_f51b049765c4fb65e756372294890310.svg) | N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide | IC50 | 3320.0 [1], 32200.0 [2], 100000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_25d9b33026565fc9b2cb6059f4773987.svg) | 2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide | IC50 | 10000.0 [1], 10300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_71450bda5f550ba3db0463b13d3782d9.svg) | Tetrodotoxin | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_c7416e1543ca26168b769dc25d1f2310.svg) | Tetracaine | IC50 | 520.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_a62cbe90f5af57b0f55ccaee19647f69.svg) | Senicapoc | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_55892479c77cb8cbec69941708da1cce.svg) | CID 46840946 | IC50 | 173.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_f5527955ab94658607e86abaefac62c1.svg) | (2S)-2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-27,57-bis(4-aminobutyl)-21-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-24-(3-amino-3-oxopropyl)-54,74-bis(3-carbamimidamidopropyl)-13,51-bis(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36,68-tris(1H-indol-3-ylmethyl)-71-(2-methylpropyl)-7,33-bis(2-methylsulfanylethyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-4-propan-2-yl-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontane-65-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | IC50 | 26.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_0655a0f80832be04b0950c13a7240f1c.svg) | 1-[2-Methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-2-oxo-N-pyrimidin-2-ylquinoline-6-sulfonamide | IC50 | 650.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_76da9ff9b1eaea839ff6bf6ca3294255.svg) | [5-(1-Benzylindazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine | IC50 | 660.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_c81436d3cbf1c35466eedc3219b90925.svg) | CID 91666633 | IC50 | 92.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_8b91225a65757402e5ee28532d30a2ca.svg) | [5-(2-Benzylindazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine | IC50 | 1030.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_42e8e96aab4c8e3ece5dee1b2eaa9ac5.svg) | 4-[4-Chloro-2-[2-(1-ethylazetidin-3-yl)pyrazol-3-yl]phenoxy]-3-cyano-N-(1,3-thiazol-4-yl)benzenesulfonamide | IC50 | 1636.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_526071f5d6a907983935b8ce39e33166.svg) | 5-Chloro-2-fluoro-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide | IC50 | 1109.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_109a9052a4f3704cfeb82e7ab56f50a0.svg) | 2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amine | IC50 | 4200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_de119abfff9f20abb9a096724bb462f5.svg) | 4-[2-(2-Amino-3H-benzimidazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 0.8 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_c845d6dbbed4ea254b11f7c86ac18aaa.svg) | 4-[2-(3-Amino-1,2-benzoxazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_da41649d64ca27df34964228f23b8832.svg) | 4-[4-Chloro-2-(2-methylpyrazol-3-yl)phenoxy]-3-fluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 510.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_6062e2101bd51941236f348cea3c774a.svg) | 4-[4-Chloro-2-(2-methylpyrazol-3-yl)phenoxy]-3-cyano-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 199.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_8889ba945b627a40a411d2b142f7e056.svg) | 4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamide | IC50 | 3700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_ba3d0dbddcb0669e9014f069801a24f3.svg) | 3-Cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 5.46 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_66d69856f0ef8731cd6abe663649906d.svg) | 1-[1-(2-Fluorophenyl)indazol-4-yl]-3-[2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl]imidazolidin-2-one | IC50 | 8600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_f867a3109129b1ce591f7eb629418ce7.svg) | 1-[5-Fluoro-2-methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-N-(1,2-oxazol-3-yl)isoquinoline-6-sulfonamide | IC50 | 16000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_786abf31dcee0e1f07502fa37feebdb1.svg) | (3Ar,6aS)-5-[1-(2-fluorophenyl)indazol-4-yl]-2-(3-hydroxy-3-methylbutanoyl)-3,3a,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrol-4-one | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_f86d7f2921e68f79b7f280f1503786e2.svg) | 1-[2-[5-Fluoro-1-(2-fluorophenyl)indazol-3-yl]oxyethyl]imidazolidin-2-one | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_3dc4835f9b6d066922f8d989c2d62671.svg) | (4S)-4-[[(2S)-6-Amino-2-[[(2S)-5-carbamimidamido-2-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-27,51,74-tris(4-aminobutyl)-24-(3-amino-3-oxopropyl)-21-[[(2S)-2-[[(2S)-2-aminopent-4-ynoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-68-[(5-bromo-1H-indol-3-yl)methyl]-33-butyl-4,54-bis(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36-bis(1H-indol-3-ylmethyl)-57-methyl-7,71-bis(2-methylpropyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontane-65-carbonyl]amino]pentanoyl]amino]hexanoyl]amino]-5-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | IC50 | 66.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_0f736de6c46940e19cfb2821064d1ffd.svg) | (4S)-4-Amino-5-[[(2S)-1-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-65-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]-27,74-bis(4-aminobutyl)-24-(3-amino-3-oxopropyl)-68-[(5-bromo-1H-indol-3-yl)methyl]-33-butyl-4,54-bis(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36-bis(1H-indol-3-ylmethyl)-51,57-dimethyl-7,71-bis(2-methylpropyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontan-21-yl]amino]-1-oxopent-4-yn-2-yl]amino]-5-oxopentanoic acid | IC50 | 104.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_45e8a6b668515b12820c2089b7609385.svg) | (4S)-4-[[(2S)-6-Amino-2-[[(2S)-5-carbamimidamido-2-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-27,51,74-tris(4-aminobutyl)-24-(3-amino-3-oxopropyl)-21-[[(2S)-2-[[(2S)-2-aminopent-4-ynoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-33-butyl-4,54-bis(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36,68-tris(1H-indol-3-ylmethyl)-57-methyl-7,71-bis(2-methylpropyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontane-65-carbonyl]amino]pentanoyl]amino]hexanoyl]amino]-5-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | IC50 | 183.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_bab3de67d1d06ffa37a3fe44a62c395c.svg) | 4-[(2R,3R)-3-(3,5-Dichlorophenyl)-6,6-dimethylmorpholin-2-yl]oxy-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 1600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_30988ce47fc7781cfc2186f4cc15faa0.svg) | N-[7-(1-Adamantylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methanesulfonamide | IC50 | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_8846e54044f2acbebb0b9e49bcb8c2b2.svg) | N-[[3-Chloro-4-(trifluoromethoxy)phenyl]methyl]-3-fluoro-4-(1,2,4-thiadiazol-5-ylsulfamoyl)benzamide | IC50 | 2100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_f048aaa9685278fd01dc1f2f4b97d5dc.svg) | N-[[3-Chloro-4-(trifluoromethoxy)phenyl]methyl]-3-fluoro-4-(1,3-thiazol-2-ylsulfamoyl)benzamide | IC50 | 1050.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-viii-alpha-subunit_7ac9b521c3da8cda7f541edca30c052d.svg) | 3-[[5-[4-(Trifluoromethoxy)phenyl]-1H-imidazol-2-yl]methyl]oxetan-3-amine | IC50 | 46000.0 [1] |